Skip to content

Opt-in vs. Opt-out for Breast Cancer Screening

Opt-in vs. Opt-out Mammography Screening Outreach: a Randomized Controlled Trial

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05313737
Enrollment
871
Registered
2022-04-06
Start date
2022-04-18
Completion date
2022-08-31
Last updated
2022-04-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Cancer

Keywords

Cancer Screening, Adherence

Brief summary

This is a randomized controlled trial that will evaluate the effectiveness two different outreach strategies for a population-based breast cancer screening program at the VA Puget Sound among average risk female Veterans who are due for breast cancer screening.

Detailed description

This is a prospective, randomized controlled trial that will evaluate the effectiveness of two different outreach strategies in improving adherence to breast cancer screening via mammography. Average risk female Veterans who are due for breast cancer screening (defined as aged 45-75 with no previous history of bilateral mastectomy, not under hospice care, and alive at the time of screening) will be identified through administrative data. Veterans eligible for enrollment into the trial will be randomized in a 1:1 allocation using permuted block randomization (with random block sizes of 2 and 4) to the following interventions: Arm 1: Automated phone opt-in message Intervention Type: Audiocare message requiring Veteran to confirm that they would like to participate in screening and have consult sent Arm 2: Opt-out scheduling Intervention Type: Consult automatically sent and Veteran called to schedule screening Randomization will be stratified within arms by prior screening status (prior screener vs. never screener). The study's primary outcome of interest is screening completion at 100 days post randomization. The study's secondary outcome of interest is screening scheduling at 100 days post randomization. Subgroup analysis aim 1 will explore whether the differences in breast cancer screening completion between investigational groups varies according to the Veterans' race/ethnicity. Subgroup analysis aim 2 will explore whether the differences in breast cancer screening scheduling between investigational groups varies according to the Veterans' race/ethnicity. Enrollment in the trial will occur between March 1, 2022 and August 31, 2022.

Interventions

OTHERAutomated message

Automated message via phone call (audiocare)

OTHEROpt-out scheduling

Scheduling via non-automated phone call

Sponsors

VA Puget Sound Health Care System
Lead SponsorFED

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SCREENING
Masking
TRIPLE (Subject, Caregiver, Investigator)

Eligibility

Sex/Gender
FEMALE
Age
45 Years to 75 Years
Healthy volunteers
Yes

Inclusion criteria

* female Veterans aged 45-75 * assigned to a primary care provider at the VA Puget Sound as of January 1, 2022 with at least 1 year of prior data available * due for breast cancer screening (have not had a mammogram in the last 12 months)

Exclusion criteria

* must not be any indication of current receipt of hospice care * no record of recent death in the administrative data * not scheduled for either a screening or diagnostic mammogram within the following 12 weeks from assessment. * not have a personal history of bilateral mastectomy.

Design outcomes

Primary

MeasureTime frameDescription
Percentage of mammograms completed at 100 days post randomization100 days post randomizationPercent of mammograms completed

Secondary

MeasureTime frameDescription
Percentage of mammograms scheduled at 100 days post randomization100 days post randomizationPercent of mammograms scheduled

Other

MeasureTime frameDescription
Percentage of mammograms cancelled at 100 days post randomization100 days post randomizationPercent of mammograms cancelled
Percentage of mammograms active at 100 days post randomization100 days post randomizationPercent of mammograms active

Countries

United States

Contacts

Primary ContactStefanie Deeds, MD
Stefanie.Deeds@va.gov206-314-0507
Backup ContactAlaina Mori, MS
Alaina.Mori@va.gov206-247-6782

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 8, 2026